ASCO Annual Meeting brought many different updates to light in the realm of hematological malignancies, including multiple ...

Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma <li /> Recommendation base ...

Innovent Biologics is pivoting to R&D and oncology growth in China, but high valuation and risks temper upside. Read why ...

Global Antibody Drug Conjugate Market is valued at approximately USD 5.60 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 16.12% over the forecast period 2024-2030.

Researchers have discovered that the most aggressive melanomas, the deadliest form of skin cancer, overactivate two key ...